Jin Kim
FounderFounder & CEO of Miracle | Former US Archery Team | MIT
Browser storage is unavailable. Keep this page open and export your collection before leaving.

Miracle is building the control room for clinical trials. Today, biotech companies rely on fragmented software systems, spreadsheet trackers, and manual processes to manage complex clinical trials. Miracle integrates and consolidates data from disparate sources into a single platform, giving teams real-time visibility, helping them identify risks e
Miracle is building the control room for clinical trials. Today, biotech companies rely on fragmented software systems, spreadsheet trackers, and manual processes to manage complex clinical trials. Miracle integrates and consolidates data from disparate sources into a single platform, giving teams real-time visibility, helping them identify risks early, and streamlining workflows to make faster, better decisions.
By unifying clinical trial data, we're also laying the foundation for AI-powered analytics and automation.
Our mission is to modernize how clinical trials are run so new treatments can reach patients faster.
Previously Miracle Health
Founder & CEO of Miracle | Former US Archery Team | MIT
Founded 2022 · Source
Source-based assessment · automated evidence rules
The company website explicitly reports customer or user adoption. This is a source-based assessment of a company claim; scale and revenue are not independently verified.
Company website: home Checked 2026-09-16
Trusted by Leading Biopharma Companies
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.